Back
NextEra Energy 10K Form
Sell
49
NEE
NextEra Energy
Last Price:
$71.56
Seasonality Move:
2.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-23 | 10Q | NEE/NextEra Energy Quarterly |
2024-02-16 | 10K | NEE/NextEra Energy Annual |
2023-11-07 | 10Q | NEE/NextEra Energy Quarterly |
2023-07-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-04-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-02-17 | 10K | NEE/NextEra Energy Annual |
Receive NEE News And Ratings
See the #1 stock for the next 7 days that we like better than NEE
NEE Financial Statistics
Sales & Book Value
Annual Sales: | $24.8B |
---|---|
Cash Flow: | $139M |
Price / Cash Flow: | 31.06 |
Annual Sales: | $24.36 |
Price / Book: | 2.94 |
Profitability
EPS (TTM): | 3.37000 |
---|---|
Net Income (TTM): | $6.9B |
Gross Margin: | $14.9B |
Return on Equity: | 11.64% |
Return on Assets: | 3.78% |
NextEra Energy Earnings Forecast
Key NextEra Energy Financial Ratios
-
The Gross Profit Margin over the past 31 years for NEE is 60.06%.
-
The Selling, General & Administrative Expenses for NEE have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 32.18% of Operating Income.
-
The Net Earning history of NEE is 28.06% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 26 years.
NextEra Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electric Utilities |
Sector: | Utilities |
Current Symbol: | NEE |
CUSIP: | 65339F |
Website: | nexteraenergy.com |
Debt
Debt-to-Equity Ratio: | 1.64 |
---|---|
Current Ratio: | 0.47 |
Quick Ratio: | 0.25 |
Price-to-Earnings
Trailing P/E Ratio: | 21.24 |
---|---|
Forward P/E Ratio: | 17.93 |
NEE Technical Analysis vs Fundamental Analysis
Sell
49
NextEra Energy (NEE)
is a Sell
Is NextEra Energy a Buy or a Sell?
-
NextEra Energy stock is rated a SellThe current NextEra Energy [NEE] share price is $71.58. The Score for NEE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.